LooK SPOT

COVID-19 Antigen Rapid Test in 5 to 8 Minutes

New SPEED mode to deliver test results in 30 seconds

Received CE IVD clearance for Europe

LooK SPOT with phone Laipac

How does it work?

The LooK SPOT System uses the smart-phone based reader LooK SPOT, the LooK COVID-19 Antigen Lateral Flow Assay Cassette, and the nasal sample to deliver a rapid diagnosis of the SARS-CoV-2 virus between 5 to 8 minutes using AI.
It provides 97.4% sensitivity and 98.3% specificity for the SARS-CoV-2 virus detection in the first 8 days of symptom onset.

Design Mission

Healthcare responders in the COVID-19 raid test sites often need to make time-sensitive decisions to determine the test results during the time many patients are within their vicinity. The information they draw upon is the instruction of use, previous training, knowledge, and intelligence from colleagues and digital sources. But the tempo, volume, stress, fatigue, lighting, and various other factors can overwhelm healthcare responders when making the visual interpretation of antigen tests for the test results. Laipac believes it is of paramount importance to reduce healthcare responders’ cognitive load by providing accurate test results in real-time. Laipac’s LocationNow AI Cloud can accurately identify the colour signal response; when human eyes cannot detect the low concentration of viral load in traditional antigen tests. LooK SPOT system is a COVID-19 rapid test solution designed with a tactical edge to fight the good fight.

Learn about the LooK SPOT COVID-19 Antigen Rapid Test's Powerful AI Technology

Watch our LooK SPOT COVID -19 Antigen Rapid Test AI Video to get more information about the LooK SPOT device and its powerful AI technology to deliver accurate test results anytime and anywhere.

For more information on the LooK SPOT COVID-19 Antigen Rapid Test, request a demo or contact our sales team.

LooK SPOT: Limit of Detection (Analytical Performance)

The LOD (Limit of Detection) studies determined the lowest detectable concentration fo SARS-CoV-2 at which at least 95% of all (true positive) replicates tested positive. The LoD for the LooK SPOT COVID-19 Rapid Antigen Test was 1.29×10⁵ TCID₅₀ /ml based on 20 replicates. This was established by spiking increasingly dilute amounts of heat-inactivated SARS-CoV-2 (ATCC® VR-1986HK™) in the nasopharyngeal extract of a COVID-19 negative donor. ATCC® VR-1986HK™ is a preparation of Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) strain 2019-nCoV/USA-WA1/2020 that has been inactivated by heating to 65°C for 30 minutes and is therefore unable to replicate.

Laipac LooK SPOT Antigen Test Cassette for COVID
LooK SPOT COVID 19 Rapid Antigen Test Advantages Laipac

LooK SPOT App

The LooK SPOT app operates the LooK SPOT reader via Bluetooth connection. Both the reader and app work together to process the test cassette and receive the test results from the LocationNow AI Cloud. It’s features include:

  • An intuitive UI design that is easy to use with step-by-step instructions
  • Connects to the LooK SPOT reader via BLE (Bluetooth)
  • Provides Auto-calibration with the calibration cassette
  • Detects the valid test cassette and discards the unknown and used test cassette
  • Takes images of the test cassette and sends them to the LocationNow AI Cloud for analysis
  • Receives and shows the test results within 5 to 8 minutes
  • Stores the test results to the History tab within the app
  • Automatically UV sterilizes the reader after each test

The minimum requirement for phone models and OS includes:

  • iPhone 6 or above, with iOS 13 or above, and 8MP rear camera or above
  • Android phones with Android OS 7.1 or above, and 8MP rear camera or above
  • A WiFi or Cell Data Connection and BLE are required for the operation

LooK PASS App for Patients

Download and use the LooK PASS app to scan the antigen cassette before the test and receive the test results on your phone in real time. The app will generate a QR code as a Day Pass when the test result comes up as negative. Save these results within your app & use the generated QR code when out of the house to show the negative test results at the point of entry. Family members can be added to the same user account. Other features include:

  • An easy user registration process
  • An intuitive UI design that is easy to use with step-by-step instructions
  • The ability to scan the QR code of the LooK COVID-19 Antigen cassette before the test
  • Receives test results within 5 to 8 minutes
  • Assigns a Day Pass QR code for users who have a negative test result. Muti-users can share the same app provided they are within the same family.
  • Saves test history for personal reference
  • Has full privacy protocol and data encryption

The minimum requirement for phone models and OS includes:

  • iPhone 6 or above, with iOS 13 or above
  • Android phones with Android OS 7.1 or above
  • A WiFi or Cell Data Connection is required for the operation

LooK SPOT: Clinical Performance

The LooK SPOT COVID-19 Antigen Rapid Test’s clinical performance was evaluated with patient specimens collected in multiple sites. In this study, 95 patients with suspected COVID-19 have participated. Patients who presented within eight (8) days of symptom onset were included in the study. There were eleven (11) asymptomatic patients, and one (1) of them was tested positive for SARS-CoV-2. A Real-Time Polymerase Chain Reaction (RT-PCR) assay was utilized as the comparator method for this study. The BioMerieux MucliSENS extraction system was used to extract total nucleic acid. Extracted nucleic acid was then amplified in three (3) separate reactions using the CDC N1, N2, and RNase P primer set using the Promega GoTaq kit on a BioRAD C.F.X. Real-time PCR system.

The collected specimens were transported in Universal Transport Medium (UTM), and all sites shipped the UTM samples to the lab centre for this clinical performance study. The samples are run as per test protocol where the swab was mixed in the extraction buffer (450uL) and left in for one (1) minute. Then apply three (3) drops (45uL) for the buffer onto the LooK COVID-19 Antigen Cassette to start the test.

LooK SPOT COVID-19 Antigen Rapid Test Performance within eight (8) days of symptom onset

FCC, IC & CE Certified

Shipping, Weight & Dimensions

LooK SPOT Reader: 6.25″ (L) x 5.5″ (W) x 3″ (H) – 0.38lbs (1pcs)
Master Carton Box of LooK SPOT Reader: 19.25″ (L) x 11.5″ (W) x 9.5″ (H) – 9lbs (18pcs)
LooK COVID-19 Antigen Cassette Kit: 9.875″ (L) x 4.125″ (W) x 2.125″ (H) – 0.35lbs (10 tests)
Master Carton Box of LooK COVID-19 Antigen Cassette Kit: 22″ (L) x 21″ (W) x 10″ (H) – 18.25lbs (400 tests)

Antigen Cassette Kit

Each Antigen Cassette Kit contains:
– Ten (10) LooK COVID-19 Antigen Cassettes with SARS-CoV-2 monoclonal antibodies individually sealed within aluminum foil bags
– One (1) dropper included within each of the individually packages antigen cassette aluminum foil bags (there are 10 in total)
– Ten (10) extraction buffer tubes containing surfactants, proteins, and salts
– Ten (10)
 sterile nasal swabs
– A package insert with instructions on how to use the kit

Step-By-Step Test Procedures

Step 1

Insert the nasal swab into the nostril where there is the most secretion or that is most congested.
Push the swab until stopping at the level of the turbinates (roughly one inch into the nostril).
Rotate the swab five (5) times or more against the nasal wall. Repeat the same process in the other nostril with the same swab.

Step 2

Place the patient’s nasal swab sample into the Extraction Buffer Tube.
Roll the swab at least five (5) times while pressing the head against the Botton and side of the tube.

Step 3

Leave the swab in the Extraction Buffer Tube for 1 minute.
Roll the swab against the inside of the Tube as you remove it.
Dispose of the used swab as biohazard waste.

Step 4

Fill the disposable dropper with the patient sample from the Extraction Buffer Tube.

Step 5

Dispense three (3) drops of the sample to the round sample window above the arrow mark on the cassette.
Be careful NOT to touch the cassette with the tip of the dropper.

Laipac's Point-of-Care Study Survey Results for the LooK SPOT COVID-19 Antigen Rapid Test

The Point-of-Care performance of LooK SPOT COVID-19 Antigen Rapid Test was evaluated in a prospective study in the US, Canada, Ireland, Norway, Italy, Japan, and UAE, in which non-laboratory personnel were sequentially enrolled, tested and surveyed. More than one hundred (100) people participated in the study, each doing multiple tests and forty-six (46) people were interviewed by the time of FDA EUA submission. Testing was performed by operators with no laboratory experience. Before the test, the operators watched a training video. After the test, the operators evaluated their performance. To be enrolled in the study, non-laboratory personnel had to register and sign a consent form, as well as discuss with Laipac’s tech support via Zoom meeting or face to face. Operators with COVID-19 symptom onset were included. Among all people tested for SARS-CoV-2, there were two (2) positive cases.

Laipac received excellent results from the Study Survey to ensure the LooK SPOT COVID-19 Antigen Rapid Test is easy to use for a trained person to operate.

LooK SPOT COVID-19 Antigen Rapid Test Training Video

Watch our LooK SPOT COVID -19 Antigen Rapid Test Training Video for Point of Care to get more information about the LooK SPOT device and how to use it for your needs & applications. 

For more information on the LooK SPOT COVID-19 Antigen Rapid Test, request a demo or contact our sales team

COVID-19 Rapid Antigen Test for Clinics & Medical Offices

The LooK SPOT COVID Rapid Test uses AI and machine learning to detect the concentration of the COVID-19 virus, displaying results in less than 5 to 8 minutes on the smartphone of the test user. With an innovative and easily adjustable mechanism to clamp around any smartphone, the LooK SPOT COVID Rapid Test is an excellent solution for dental clinics, ophthalmologist offices, cosmetic offices, hospitals, hair salons and other medical offices to prescreen all visitors and patients before attending.

LooK SPOT clinic check

Trade Show INDEX in UAE

Watch our UAE: New AI-powered rapid COVID-19 test video to learn more about the powerful AI technology behind the LooK SPOT device. 

LooK SPOT – COVID-19 Antigen Rapid Test will be on display at the International Defence Exhibition (IDEX) in Abu Dhabi.

For more information on the LooK SPOT COVID-19 Antigen Rapid Test, request a demo or contact our sales team

LooK SPOT airport check Laipac

COVID-19 Rapid Antigen Test for Airports, Transportation & Travel

Using the LooK SPOT COVID Rapid Test can help eliminate the fear of COVID-19 infection with fast and accurate testing. The portable COVID-19 Test works in less than 5 to 8 minutes with 97.4% sensitivity, reducing the fear of air travel by assuring all passengers are COVID-19 negative. Look SPOT can reduce stress for airline workers and passengers, allowing more seats to be filled and promoting the revival of the travel industry.

LooK SPOT

The low-cost, smartphone-based Rapid Antigen Test Kit to detect COVID-19